Attachment

8. 9. 10. 11. 12. 13. 14. 15. Richard Hatchett -- CEPI* Kendall Hoyt -- Dartmouth Marc Lipsitch -- Harvard Prof of Public Health Epidemiologist* Dave Robinson -- Gates Foundation, Director, CMC Vaccines Development and Surveillance (as an observer) James Robinson -- indep consultant, former Merck, working with CEPI* David Stump -- Genentech and Human Genome director of Clinical Trials* Rajeev Venkayya -- Takeda Pharma; respiratory physician* Dick Wilder -- CEPI (retired) Additional people invited to participate in Tuesday call. dy aypwn Luciana Borio, InQTel, former director of National Security Council Directorate for Medical and Biodefense Preparedness; former Chief Scientist at FDA Tom Inglesby, Director, Johns Hopkins Center for Health Security Tom Kalil, Schmidt Futures (former Deputy Director, Office of Technology Policy) Chris Kirchhoff, Schmidt Futures (author of NSC Ebola Review) Jason Matheny, former head of the Intelligence Advanced Research Projects Activity) Mike Osterholm, Director, Center for Infectious Disease Research & Policy, University of Minnesota ' WHO and the Milken Institute have compiled lists of over forty initiatives. CEPI is compiling a more comprehensive list on the order of twice that number. "See Thomas C. Darton, et al., "Design, Recruitment and Microbiological Considerations in Human Challenge Studies," The Lancet Infectious Diseases (May 2015). "I Kendall Hoyt, Long Shot p. 73.